Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Liudmila Cebotaru

Showing results (1-10 of 62) with videos related to

Pageof 7
Sort By:
American Journal of Physiology. Cell Physiology|April 16, 2025
AAV1-CFTR preferentially transduces cysts and reduces cyst size in a mouse model of ADPKDCristian Ciobanu, Liudmila Cebotaru
Expert Opinion on Biological Therapy|June 29, 2017
Adeno-Associated Virus (AAV) gene therapy for cystic fibrosis: current barriers and recent developmentsWilliam B Guggino, Liudmila Cebotaru
Biophysical Reviews|June 21, 2014
Complement yourself: Transcomplementation rescues partially folded mutant proteinsLiudmila Cebotaru, William B Guggino
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 18, 2021
VX-809 mitigates disease in a mouse model of autosomal dominant polycystic kidney disease bearing the R3277C human mutationMurali K Yanda, Liudmila Cebotaru
Human Gene Therapy|April 15, 2020
Gene Therapy for Cystic Fibrosis Paved the Way for the Use of Adeno-Associated Virus in Gene TherapyWilliam B Guggino, Liudmila Cebotaru
Cellular and Molecular Gastroenterology and Hepatology|July 30, 2021
Therapeutic Potential for CFTR Correctors in Autosomal Recessive Polycystic Kidney DiseaseMurali K Yanda, Vartika Tomar, Liudmila Cebotaru
The Journal of Biological Chemistry|June 8, 2018
A potential strategy for reducing cysts in autosomal dominant polycystic kidney disease with a CFTR correctorMurali K Yanda, Qiangni Liu, Liudmila Cebotaru
American Journal of Physiology. Renal Physiology|July 28, 2017
An inhibitor of histone deacetylase 6 activity, ACY-1215, reduces cAMP and cyst growth in polycystic kidney diseaseMurali K Yanda, Qiangni Liu, Liudmila Cebotaru
American Journal of Physiology. Gastrointestinal and Liver Physiology|March 7, 2023
Ameliorating liver disease in an autosomal recessive polycystic kidney disease mouse modelMurali K Yanda, Adi Zeidan, Liudmila Cebotaru
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|June 22, 2011
Polycystin-1, 2, and STIM1 interact with IP(3)R to modulate ER Ca release through the PI3K/Akt pathwayNetty G Santoso, Liudmila Cebotaru, William B Guggino
Pageof 7

Showing results (1-10 of 62) with videos related to

Sort By:
Pageof 7
American Journal of Physiology. Cell Physiology|April 16, 2025
AAV1-CFTR preferentially transduces cysts and reduces cyst size in a mouse model of ADPKDCristian Ciobanu, Liudmila Cebotaru
Expert Opinion on Biological Therapy|June 29, 2017
Adeno-Associated Virus (AAV) gene therapy for cystic fibrosis: current barriers and recent developmentsWilliam B Guggino, Liudmila Cebotaru
Biophysical Reviews|June 21, 2014
Complement yourself: Transcomplementation rescues partially folded mutant proteinsLiudmila Cebotaru, William B Guggino
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 18, 2021
VX-809 mitigates disease in a mouse model of autosomal dominant polycystic kidney disease bearing the R3277C human mutationMurali K Yanda, Liudmila Cebotaru
Human Gene Therapy|April 15, 2020
Gene Therapy for Cystic Fibrosis Paved the Way for the Use of Adeno-Associated Virus in Gene TherapyWilliam B Guggino, Liudmila Cebotaru
Cellular and Molecular Gastroenterology and Hepatology|July 30, 2021
Therapeutic Potential for CFTR Correctors in Autosomal Recessive Polycystic Kidney DiseaseMurali K Yanda, Vartika Tomar, Liudmila Cebotaru
The Journal of Biological Chemistry|June 8, 2018
A potential strategy for reducing cysts in autosomal dominant polycystic kidney disease with a CFTR correctorMurali K Yanda, Qiangni Liu, Liudmila Cebotaru
American Journal of Physiology. Renal Physiology|July 28, 2017
An inhibitor of histone deacetylase 6 activity, ACY-1215, reduces cAMP and cyst growth in polycystic kidney diseaseMurali K Yanda, Qiangni Liu, Liudmila Cebotaru
American Journal of Physiology. Gastrointestinal and Liver Physiology|March 7, 2023
Ameliorating liver disease in an autosomal recessive polycystic kidney disease mouse modelMurali K Yanda, Adi Zeidan, Liudmila Cebotaru
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|June 22, 2011
Polycystin-1, 2, and STIM1 interact with IP(3)R to modulate ER Ca release through the PI3K/Akt pathwayNetty G Santoso, Liudmila Cebotaru, William B Guggino
Pageof 7